{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:35:27Z","timestamp":1707525327471},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,13]]},"DOI":"10.7759\/cureus.46969","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T13:49:31Z","timestamp":1697204971000},"source":"Crossref","is-referenced-by-count":0,"title":["Is There a Relationship Between First-Trimester Aneuploidy Screening Serum Biomarker Values and Nuchal Translucency Measurements and the Development of Retinopathy of Prematurity (ROP) in Premature Infants?"],"prefix":"10.7759","author":[{"given":"Mehmet Fatih","family":"K\u00fc\u00e7\u00fck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan Basri","family":"Sava\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elcin","family":"Suren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammet","family":"Erol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00fctfiye","family":"Yaprak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senol","family":"Sabanci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"142","author":"Fierson WM","year":"2018","unstructured":"Fierson WM. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018, 142:10.1542\/peds.2018-3061","journal-title":"Pediatrics"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-311789","article-title":"Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units","volume":"102","author":"Bas AY","year":"2018","unstructured":"Bas AY, Demirel N, Koc E, Ulubas Isik D, Hirfanoglu \u0130M, Tunc T. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units. Br J Ophthalmol. 2018, 102:1711-6. 10.1136\/bjophthalmol-2017-311789","journal-title":"Br J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2018.1529162","article-title":"First-trimester serum biomarker screening for fetal Down syndrome as a predictor of preterm delivery: a population-based study","volume":"33","author":"Pornwattanakrilert W","year":"2020","unstructured":"Pornwattanakrilert W, Sekararithi R, Wanapirak C, et al.. First-trimester serum biomarker screening for fetal Down syndrome as a predictor of preterm delivery: a population-based study. J Matern Fetal Neonatal Med. 2020, 33:1717-24. 10.1080\/14767058.2018.1529162","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb11618.x","article-title":"First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications","volume":"107","author":"Ong CY","year":"2000","unstructured":"Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG. 2000, 107:1265-70. 10.1111\/j.1471-0528.2000.tb11618.x","journal-title":"BJOG"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5001","article-title":"Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis","volume":"37","author":"Morris RK","year":"2017","unstructured":"Morris RK, Bilagi A, Devani P, Kilby MD. Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis. Prenat Diagn. 2017, 37:253-65. 10.1002\/pd.5001","journal-title":"Prenat Diagn"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5896","article-title":"Abnormal nuchal translucency followed by normal microarray analysis is associated with placental pathology-related complications","volume":"41","author":"Krispin E","year":"2021","unstructured":"Krispin E, Kushnir A, Shemer A, Rienstein S, Berkenstadt M, Yinon Y, Weisz B. Abnormal nuchal translucency followed by normal microarray analysis is associated with placental pathology-related complications. Prenat Diagn. 2021, 41:855-60. 10.1002\/pd.5896","journal-title":"Prenat Diagn"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0223(199912)19:12<1104::aid-pd707>3.0.co;2-2","article-title":"Pregnancy outcome and nuchal translucency measurements in fetuses with a normal karyotype","volume":"19","author":"Pajkrt E","year":"1999","unstructured":"Pajkrt E, Mol BW, Bleker OP, Bilardo CM. Pregnancy outcome and nuchal translucency measurements in fetuses with a normal karyotype. Prenat Diagn. 1999, 19:1104-8. 10.1002\/(sici)1097-0223(199912)19:12&lt;1104::aid-pd707&gt;3.0.co;2-2","journal-title":"Prenat Diagn"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-019-0580-8","article-title":"The postnatal presence of human chorionic gonadotropin in preterm infants and its potential inverse association with retinopathy of prematurity","volume":"87","author":"Movsas TZ","year":"2020","unstructured":"Movsas TZ, Paneth N, Gewolb IH, Lu Q, Cavey G, Muthusamy A. The postnatal presence of human chorionic gonadotropin in preterm infants and its potential inverse association with retinopathy of prematurity. Pediatr Res. 2020, 87:558-63. 10.1038\/s41390-019-0580-8","journal-title":"Pediatr Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-2996","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"131","author":"Fierson WM","year":"2013","unstructured":"Fierson WM. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013, 131:189-95. 10.1542\/peds.2012-2996","journal-title":"Pediatrics"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity revisited","volume":"123","year":"2005","unstructured":"The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005, 123.991-9. 10.1001\/archopht.123.7.991","journal-title":"Arch Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","unstructured":"Revised indications for the treatment of retinopathy of prematurity. results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003, 121:1684-94. 10.1001\/archopht.121.12.1684","journal-title":"Arch Ophthalmol"},{"key":"ref12","article-title":"ACOG Committee Opinion #296: first-trimester screening for fetal aneuploidy","volume":"104","year":"2004","unstructured":"ACOG Committee Opinion #296. first-trimester screening for fetal aneuploidy. Obstet Gynecol. 2004, 104:215-7.","journal-title":"Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.4.8430","article-title":"Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth","volume":"87","author":"Smith GC","year":"2002","unstructured":"Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab. 2002, 87:1762-7. 10.1210\/jcem.87.4.8430","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s1472-6483(10)61899-8","article-title":"Blood biochemistry and endocrinology in the human fetus between 11 and 17 weeks of gestation","volume":"1","author":"Jauniaux E","year":"2000","unstructured":"Jauniaux E, Pahal G, Gervy C, Gulbis B. Blood biochemistry and endocrinology in the human fetus between 11 and 17 weeks of gestation. Reprod Biomed Online. 2000, 1:38-44. 10.1016\/s1472-6483(10)61899-8","journal-title":"Reprod Biomed Online"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052567","article-title":"Chorionic gonadotropin and its receptor are both expressed in human retina, possible implications in normal and pathological conditions","volume":"7","author":"Dukic-Stefanovic S","year":"2012","unstructured":"Dukic-Stefanovic S, Walther J, Wosch S, Zimmermann G, Wiedemann P, Alexander H, Claudepierre T. Chorionic gonadotropin and its receptor are both expressed in human retina, possible implications in normal and pathological conditions. PLoS One. 2012, 7:e52567. 10.1371\/journal.pone.0052567","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m A","year":"2013","unstructured":"Hellstr\u00f6m A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013, 382:1445-57. 10.1016\/S0140-6736(13)60178-6","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2018.1495740","article-title":"Elimination of signaling by the luteinizing hormone receptor reduces ocular VEGF and retinal vascularization during mouse eye development","volume":"43","author":"Movsas TZ","year":"2018","unstructured":"Movsas TZ, Sigler R, Muthusamy A. Elimination of signaling by the luteinizing hormone receptor reduces ocular VEGF and retinal vascularization during mouse eye development. Curr Eye Res. 2018, 43:1286-9. 10.1080\/02713683.2018.1495740","journal-title":"Curr Eye Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2018.1467932","article-title":"Vitreous levels of luteinizing hormone and VEGF are strongly correlated in healthy mammalian eyes","volume":"43","author":"Movsas TZ","year":"2018","unstructured":"Movsas TZ, Sigler R, Muthusamy A. Vitreous levels of luteinizing hormone and VEGF are strongly correlated in healthy mammalian eyes. Curr Eye Res. 2018, 43:1041-4. 10.1080\/02713683.2018.1467932","journal-title":"Curr Eye Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0000000000001140","article-title":"The potential effect of human chorionic gonadotropin on vasoproliferative disorders of the immature retina","volume":"29","author":"Movsas TZ","year":"2018","unstructured":"Movsas TZ, Muthusamy A. The potential effect of human chorionic gonadotropin on vasoproliferative disorders of the immature retina. Neuroreport. 2018, 29:1525-9. 10.1097\/WNR.0000000000001140","journal-title":"Neuroreport"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara N","year":"2004","unstructured":"Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004, 25:581-611. 10.1210\/er.2003-0027","journal-title":"Endocr Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2015.15","article-title":"VEGF mRNA and protein concentrations in the developing human eye","volume":"77","author":"Ma IT","year":"2015","unstructured":"Ma IT, McConaghy S, Namachivayam K, et al.. VEGF mRNA and protein concentrations in the developing human eye. Pediatr Res. 2015, 77:500-5. 10.1038\/pr.2015.15","journal-title":"Pediatr Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2017.09.002","article-title":"Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective","volume":"62","author":"Chan-Ling T","year":"2018","unstructured":"Chan-Ling T, Gole GA, Quinn GE, Adamson SJ, Darlow BA. Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective. Prog Retin Eye Res. 2018, 62:77-119. 10.1016\/j.preteyeres.2017.09.002","journal-title":"Prog Retin Eye Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.102.007609","article-title":"Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation","volume":"68","author":"Monget P","year":"2003","unstructured":"Monget P, Mazerbourg S, Delpuech T, et al.. Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation. Biol Reprod. 2003, 68:77-86. 10.1095\/biolreprod.102.007609","journal-title":"Biol Reprod"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20020831","article-title":"Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis","volume":"367","author":"Laursen LS","year":"2002","unstructured":"Laursen LS, Overgaard MT, Nielsen CG, et al.. Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis. Biochem J. 2002, 367:31-40. 10.1042\/BJ20020831","journal-title":"Biochem J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.111035","article-title":"Disorders of IGFs and IGF-1R signaling pathways","volume":"518","author":"Forbes BE","year":"2020","unstructured":"Forbes BE, Blyth AJ, Wit JM. Disorders of IGFs and IGF-1R signaling pathways. Mol Cell Endocrinol. 2020, 518:111035. 10.1016\/j.mce.2020.111035","journal-title":"Mol Cell Endocrinol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1210\/er.2001-0033","article-title":"Cellular actions of the insulin-like growth factor binding proteins","volume":"23","author":"Firth SM","year":"2002","unstructured":"Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002, 23:824-54. 10.1210\/er.2001-0033","journal-title":"Endocr Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.101113998","article-title":"Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity","volume":"98","author":"Hellstrom A","year":"2001","unstructured":"Hellstrom A, Perruzzi C, Ju M, et al.. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A. 2001, 98:5804-8. 10.1073\/pnas.101113998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.10.033","article-title":"rhIGF-1\/rhIGFBP-3 in preterm infants: a phase 2 randomized controlled trial","volume":"206","author":"Ley D","year":"2019","unstructured":"Ley D, Hallberg B, Hansen-Pupp I, et al.. rhIGF-1\/rhIGFBP-3 in preterm infants: a phase 2 randomized controlled trial. J Pediatr. 2019, 206:56-65.e8. 10.1016\/j.jpeds.2018.10.033","journal-title":"J Pediatr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2017.60.2.154","article-title":"Maternal serum placental growth factor and pregnancy-associated plasma protein A measured in the first trimester as parameters of subsequent pre-eclampsia and small-for-gestational-age infants: a prospective observational study","volume":"60","author":"Sung KU","year":"2017","unstructured":"Sung KU, Roh JA, Eoh KJ, Kim EH. Maternal serum placental growth factor and pregnancy-associated plasma protein A measured in the first trimester as parameters of subsequent pre-eclampsia and small-for-gestational-age infants: a prospective observational study. Obstet Gynecol Sci. 2017, 60:154-62. 10.5468\/ogs.2017.60.2.154","journal-title":"Obstet Gynecol Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S1028-4559(10)60029-0","article-title":"Pathophysiology of increased fetal nuchal translucency thickness","volume":"49","author":"Chen CP","year":"2010","unstructured":"Chen CP. Pathophysiology of increased fetal nuchal translucency thickness. Taiwan J Obstet Gynecol. 2010, 49:133-8. 10.1016\/S1028-4559(10)60029-0","journal-title":"Taiwan J Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/194921-is-there-a-relationship-between-first-trimester-aneuploidy-screening-serum-biomarker-values-and-nuchal-translucency-measurements-and-the-development-of-retinopathy-of-prematurity-rop-in-premature-infants","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:06:21Z","timestamp":1707509181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/194921-is-there-a-relationship-between-first-trimester-aneuploidy-screening-serum-biomarker-values-and-nuchal-translucency-measurements-and-the-development-of-retinopathy-of-prematurity-rop-in-premature-infants"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.46969","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,13]]}}}